Portal Investigación UEx

PORTAL DE INVESTIGACIÓN

REVISTA

PHARMACOGENOMICS JOURNAL

ISSN

1470-269X

EISSN

1473-1150

JCR 2024: 2.9

Mejor cuartil: Q2

SJR 2024: 0.694

Mejor cuartil: Q2

PUBLICACIONES DE LA UEX

Pharmacogenomic Biomarker Information On Drug Labels Of The Spanish Agency Of Medicines And Sanitary Products: Evaluation And Comparison With Other Regulatory Agencies (2024)

Relationships Between Cyp1a2, Cyp2c9, Cyp2c19, Cyp2d6 And Cyp3a4 Metabolic Phenotypes And Genotypes In A Nicaraguan Mestizo Population (2021)

Association Between Endothelial Nitric Oxide Synthase (Nos3) Rs2070744 And The Risk For Migraine (2020)

Association Of Polymorphisms In Leptin And Adiponectin Genes With Long-Term Outcomes In Renal Transplant Recipients (2020)

Influence Of Genetic Variants And Antiepileptic Drug Co-Treatment On Lamotrigine Plasma Concentration In Mexican Mestizo Patients With Epilepsy (2020)

Polymorphisms In Cep68 Gene Associated With Risk Of Immediate Selective Reactions To Non-Steroidal Anti-Inflammatory Drugs (2019)

Gamma-Aminobutyric Acid (Gaba) Receptors Genes Polymorphisms And Risk For Restless Legs Syndrome (2018)

Genetic Structure Of Pharmacogenetic Biomarkers In Brazil Inferred From A Systematic Review And Population-Based Cohorts: A Ribef/epigen-Brazil Initiative (2018)

High Frequency Of Cyp2d6 Ultrarapid Metabolizer Genotypes In An Ashkenazi Jewish Population From Argentina (2017)

Cyp2c9, Cyp2c19, Abcb1 Genetic Polymorphisms And Phenytoin Plasma Concentrations In Mexican-Mestizo Patients With Epilepsy (2016)

High Frequency Of Cyp2d6 Ultrarapid Metabolizers In Spain: Controversy About Their Misclassification In Worldwide Population Studies (2016)

Interethnic Variation Of Cyp2c19 Alleles, 'predicted' Phenotypes And 'measured' Metabolic Phenotypes Across World Populations (2016)

Pharmacogenetic Study Of Antipsychotic Induced Acute Extrapyramidal Symptoms In A First Episode Psychosis Cohort: Role Of Dopamine, Serotonin And Glutamate Candidate Genes (2016)

A Combined High Cyp2d6-Cyp2c19 Metabolic Capacity Is Associated With The Severity Of Suicide Attempt As Measured By Objective Circumstances (2015)

High Frequency And Founder Effect Of The Cyp3a4∗20 Loss-Of-Function Allele In The Spanish Population Classifies Cyp3a4 As A Polymorphic Enzyme (2015)

Impact Of Negr1 Genetic Variability On Psychological Traits Of Patients With Eating Disorders (2015)

Pharmacogenomic Information In Drug Labels: European Medicines Agency Perspective (2015)

Interethnic Differences In The Relevance Of Cyp2c9 Genotype And Environmental Factors For Diclofenac Metabolism In Hispanics From Cuba And Spain (2014)

Association Of Common Genetic Variants With Risperidone Adverse Events In A Spanish Schizophrenic Population (2013)

Influence Of Admixture Components On Cyp2c9*2 Allele Frequency In Eight Indigenous Populations From Northwest Mexico (2013)

Neurological Toxicity After Phenytoin Infusion In A Pediatric Patient With Epilepsy: Influence Of Cyp2c9, Cyp2c19 And Abcb1 Genetic Polymorphisms (2013)

Use Of Pharmacogenetics In Bioequivalence Studies To Reduce Sample Size: An Example With Mirtazapine And Cyp2d6 (2013)

Cyp2d6 Genotype And Debrisoquine Hydroxylation Phenotype In Cubans And Nicaraguans (2012)

Cyp2d6 Polymorphism In Patients With Eating Disorders (2012)

Cyp2c9 Allele Frequency Differences Between Populations Of Mexican-Mestizo, Mexican-Tepehuano, And Spaniards (2011)

WEB ACCESIBLE

GESTIONAR COOKIES

1